Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-077670

Options or other derivatives

  • Director acquired 500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Furey John Director 2023-07-03 Grant or award · Option to purchase Ordinary Shares +500,000 500,000 D
Loading xslF345X04/tm2320409-6_4seq1.xml…